1. Choleretic and hypolipidemic effects of high levels of soluble endoglin in mice. (August 2018) Authors: Dolezelova, E.; Prasnicka, A.; Cermanova, J.; Hroch, M.; Hyspler, R.; Ticha, A.; Pericacho, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 275(2018) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High Soluble Endoglin Levels Affect Bile Acids And Cholesterol Metabolism In Mice Liver. (August 2019) Authors: Dolezelova, E.; Prasnicka, A.; Sá, I.C.I.; Hroch, M.; Hyspler, R.; Ticha, A.; Pericacho, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. High soluble endoglin levels, do not modulate cholesterol and bile acids metabolism in NASH mouse model. (December 2020) Authors: Igreja E Sá, I.C.; Prasnicka, A.; Lastuvkova, H.; Hroch, M.; Hyspler, R.; Tripská, K.; Vicen, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Labetalol treatment aggravates estrogen-induced cholestasis. (August 2021) Authors: Sá, I. C. Igreja; Tripká, K.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Labetalol treatment in estrogen-induced cholestasis – A pilot study. (December 2020) Authors: Igreja E Sá, I.C.; Tripská, K.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modification Of Bile Acid Homeostasis By Iron Overload In Rats. (August 2019) Authors: Prašnická, A.; Lastuvkova, H.; Cermanova, J.; Hroch, M.; Mokry, J.; Dolezelova, E.; Faradonbeh, F. Alaei; Zizalova, K.; Vitek, L.; Nachtigal, P.; Micuda, S. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Soluble endoglin as a potential biomarker of nash development, participating in aggravation of nash-related changes in mouse liver. (August 2021) Authors: Igreja Sá, I.C.; Tripká, K.; Lastuvkova, H.; Hroch, M.; Hyspler, R.; Dolezelova, E.; Eissazadeh, S.; Vasinova, M.; Micuda, S.; Nachtigal, P. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗